Reward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 27718159)

Published in Adv Ther on October 07, 2016

Authors

Candida J Rebello1, Frank L Greenway2

Author Affiliations

1: Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA, 70808, USA.
2: Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA, 70808, USA. Frank.Greenway@pbrc.edu.

Articles citing this

The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg. Diabetol Metab Syndr (2017) 0.75

Off-label drugs for weight management. Diabetes Metab Syndr Obes (2017) 0.75

Diabetes Care: Inspiration from Sikhism. Indian J Endocrinol Metab (2017) 0.75

Articles cited by this

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci (2002) 33.22

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09

Central nervous system control of food intake. Nature (2000) 15.85

The global obesity pandemic: shaped by global drivers and local environments. Lancet (2011) 13.23

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res (1985) 13.14

Central nervous system control of food intake and body weight. Nature (2006) 11.89

Mechanisms linking obesity with cardiovascular disease. Nature (2006) 9.07

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07

Parsing reward. Trends Neurosci (2003) 7.88

The mesolimbic dopamine reward circuit in depression. Biol Psychiatry (2006) 7.62

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet (2013) 7.34

Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med (2010) 6.63

From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol (1980) 5.46

The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci (2002) 4.70

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (2010) 4.23

Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med (1998) 2.89

Activation of central melanocortin pathways by fenfluramine. Science (2002) 2.71

Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53

Development and validation of the food-craving inventory. Obes Res (2002) 2.41

Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring) (2010) 2.25

Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron (2006) 2.16

GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes (2014) 2.13

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord (2001) 2.08

Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2015) 2.05

The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One (2013) 1.95

Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals. Int J Obes (Lond) (2009) 1.84

Interactions between the "cognitive" and "metabolic" brain in the control of food intake. Physiol Behav (2007) 1.81

Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology (2007) 1.78

Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies. Physiol Behav (2012) 1.68

Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring) (2012) 1.66

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring) (2013) 1.60

Metabolic and hedonic drives in the neural control of appetite: who is the boss? Curr Opin Neurobiol (2011) 1.60

Liking vs. wanting food: importance for human appetite control and weight regulation. Neurosci Biobehav Rev (2007) 1.52

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology (1999) 1.46

Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Addiction (2006) 1.37

Food cravings in a college population. Appetite (1991) 1.27

Neurophysiological pathways to obesity: below awareness and beyond individual control. Diabetes (2008) 1.26

Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur J Neurosci (2007) 1.25

The role of gut hormones and the hypothalamus in appetite regulation. Endocr J (2010) 1.24

Food cravings in young and elderly adults. Appetite (1997) 1.24

Food cravings discriminate differentially between successful and unsuccessful dieters and non-dieters. Validation of the Food Cravings Questionnaires in German. Appetite (2011) 1.24

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology (1998) 1.22

Regulation of body weight in humans. Physiol Rev (1999) 1.22

Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther (2000) 1.21

Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol (2007) 1.20

Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother (2006) 1.20

Naltrexone for the management of alcohol dependence. N Engl J Med (2008) 1.18

Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res (2000) 1.13

Food liking and craving: A cross-cultural approach. Appetite (1999) 1.11

Pharmacological approaches to appetite suppression. Trends Pharmacol Sci (1991) 1.11

The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology (2011) 1.11

The modified Trait and State Food-Cravings Questionnaires: development and validation of a general index of food craving. Appetite (2006) 1.10

The psychology of food craving. Proc Nutr Soc (2007) 1.08

Control of human appetite: implications for the intake of dietary fat. Annu Rev Nutr (1996) 1.08

A free-choice high-fat high-sugar diet induces changes in arcuate neuropeptide expression that support hyperphagia. Int J Obes (Lond) (2009) 1.07

Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect. Physiol Behav (1997) 1.01

Selective effects of naltrexone on food pleasantness and intake. Physiol Behav (1996) 0.99

Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss. Pharmacol Res (2014) 0.93

Food cue reactivity and craving predict eating and weight gain: a meta-analytic review. Obes Rev (2015) 0.92

Overconsumption and obesity: peptides and susceptibility to weight gain. Regul Pept (2008) 0.91

How Relevant is Food Craving to Obesity and Its Treatment? Front Psychiatry (2014) 0.90

Hypothalamic opioid-melanocortin appetitive balance and addictive craving. Med Hypotheses (2011) 0.88

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia (2016) 0.88

Do viscous polysaccharides slow absorption by inhibiting diffusion or convection? Eur J Clin Nutr (1988) 0.88

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia (2015) 0.86

Chloroplast membranes retard fat digestion and induce satiety: effect of biological membranes on pancreatic lipase/co-lipase. Biochem J (2007) 0.86

Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women. Appetite (2014) 0.86

Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans. Diabetes Obes Metab (2015) 0.85

Metabolic determinants of binge eating. Addict Behav (1997) 0.85

Inconsistencies in the assessment of food intake. Am J Physiol Endocrinol Metab (2012) 0.84

A Systematic Review of the Application And Correlates of YFAS-Diagnosed 'Food Addiction' in Humans: Are Eating-Related 'Addictions' a Cause for Concern or Empty Concepts? Obes Facts (2015) 0.83

Value and probability coding in a feedback-based learning task utilizing food rewards. J Neurophysiol (2014) 0.83

Safety and efficacy of lorcaserin: a combined analysis of the BLOOM and BLOSSOM trials. Postgrad Med (2014) 0.83

Gender-related Differences in Food Craving and Obesity. Yale J Biol Med (2016) 0.83

Preliminary validation and principal components analysis of the Control of Eating Questionnaire (CoEQ) for the experience of food craving. Eur J Clin Nutr (2015) 0.83

Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study. Metabolism (2016) 0.82

The gut-brain axis in obesity. Best Pract Res Clin Gastroenterol (2014) 0.82

Consumption of thylakoid-rich spinach extract reduces hunger, increases satiety and reduces cravings for palatable food in overweight women. Appetite (2015) 0.79

Therapeutic Potential of 5-HT2C Receptor Agonists for Addictive Disorders. ACS Chem Neurosci (2015) 0.79

Acute Effects of a Spinach Extract Rich in Thylakoids on Satiety: A Randomized Controlled Crossover Trial. J Am Coll Nutr (2015) 0.78

Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses. Br J Pharmacol (2015) 0.77

Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: A comprehensive meta-analysis. Eur Neuropsychopharmacol (2016) 0.77

Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems. Neurosci Biobehav Rev (2016) 0.76

Effects of a meal replacement system alone or in combination with phentermine on weight loss and food cravings. Obesity (Silver Spring) (2016) 0.75